Godavari Drugs Ltd.

View in App
86.60 -0.85 ▼-1.0%

09 June 2023, 04:01:00 PM
Volume: 4,891

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.godavaridrugs.com
Market Cap 66.23 Cr.
Enterprise Value(EV) 99.73 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 5.03 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 17.49 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 44.38 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.98 Calculated using Price: 87.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.75 Cr. 7,530,500 Shares
FaceValue 10
About Godavari Drugs Ltd.
The company's principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Godavari Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Godavari Drugs Ltd. Performance

View details >>
1 Day
-0.97%
1 Week
-3.71%
1 Month
+12.48%
3 Month
+9.70%
6 Month
+39.45%
1 Year
+28.97%
2 Year
+44.09%
5 Year
+214.91%
10 Year
+862.22%

Godavari Drugs Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.77 32.32 9.84 11.81 4.99 6.85 10.39 18.49 19.42
Return on Capital Employed (%) 8.18 32.30 15.77 16.89 11.01 12.14 11.80 17.58 18.35
Return on Assets (%) 10.41 14.70 3.17 3.41 1.40 1.77 2.54 4.72 5.45

Godavari Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 10 13 14 16 17 18 20 24 30 33
Non Curr. Liab. 2 5 5 6 9 9 12 16 14 14
Curr. Liab. 3 17 31 34 37 46 51 51 58 74
Minority Int.
Equity & Liab. 15 35 51 56 63 74 84 91 101 121
Non Curr. Assets 8 8 10 13 16 17 23 24 27 34
Curr. Assets 6 27 40 43 47 56 61 68 74 87
Misc. Exp. not W/O
Total Assets 15 35 51 56 63 74 84 91 101 121

Godavari Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 9 55 71 76 64 84 96 123 161 160
Other Income 0 0 0 1 1 0 0 0 0 1
Total Income 10 55 71 76 65 84 96 123 161 160
Total Expenditure -8 -49 -67 -70 -60 -78 -90 -113 -150 -150
PBIDT 2 6 5 6 5 6 6 10 12 11
Interest 0 -1 -2 -3 -2 -3 -3 -3 -3 -4
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -2 -2
Taxation 1 -1 -1 -1 0 -1 0 -2 -2 -1
Exceptional Items 0
PAT 2 4 1 2 1 1 2 4 5 4
Adjusted EPS 2 5 2 2 1 2 3 5 7 5

Godavari Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 2 -6 -5 5 4 4 6 1 11
Cash Fr. Inv. -1 -2 0 -2 -3 -3 -2 -7 -1 -5
Cash Fr. Finan. 1 0 6 7 -2 0 -1 0 0 -6
Net Change 0 0 0 0 0 1 0 0 0 1
Cash & Cash Eqvt 0 0 0 1 1 2 2 1 2 2

Godavari Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 55.86 56.13 56.13 56.13 56.36 56.92 56.92 53.12 53.12
Public 44.14 43.87 43.87 43.87 43.64 43.08 43.08 46.88 46.88
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 14.09 14.51 14.51 5.18 5.16 5.11 5.11 1.25 0.12

Godavari Drugs Ltd. Announcements

View details >>
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sushma Kakani
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prashant Shrimal
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mohit Jaju

Godavari Drugs Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
S Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Godavari Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Godavari Drugs Ltd. FAQ's

What is Godavari Drugs share price?
Can I buy Godavari Drugs shares now?
What is the Market Cap of Godavari Drugs?
What are the key metrics to analyse Godavari Drugs?
What is the 52 Week High and Low of Godavari Drugs?
What is the trend of Godavari Drugs share price?